Search Results

There are 8053223 results for: content related to: Serendipitous rapid detoxification from opiates: the importance of time-dependent processes

  1. Baseline characteristics of patients predicting suitability for rapid naltrexone induction

    The American Journal on Addictions

    Volume 24, Issue 3, April 2015, Pages: 258–264, Shanthi Mogali, Nabil A. Khan, Esther S. Drill, Martina Pavlicova, Maria A. Sullivan, Edward Nunes and Adam Bisaga

    Version of Record online : 23 APR 2015, DOI: 10.1111/ajad.12180

  2. You have free access to this content
    Naltrexone Depot Formulations for Opioid and Alcohol Dependence: A Systematic Review

    CNS Neuroscience & Therapeutics

    Volume 17, Issue 6, December 2011, Pages: 629–636, Philipp P. Lobmaier, Nikolaj Kunøe, Michael Gossop and Helge Waal

    Version of Record online : 23 SEP 2010, DOI: 10.1111/j.1755-5949.2010.00194.x

  3. A systematic review and meta-analysis of naltrexone implants for the treatment of opioid dependence

    Drug and Alcohol Review

    Volume 33, Issue 2, March 2014, Pages: 115–128, Sarah Larney, Linda Gowing, Richard P. Mattick, Michael Farrell, Wayne Hall and Louisa Degenhardt

    Version of Record online : 3 DEC 2013, DOI: 10.1111/dar.12095

  4. Naltrexone in the treatment of opioid-dependent pregnant women: the case for a considered and measured approach to research

    Addiction

    Volume 108, Issue 2, February 2013, Pages: 233–247, Hendrée E. Jones, Margaret S. Chisolm, Lauren M. Jansson and Mishka Terplan

    Version of Record online : 4 APR 2012, DOI: 10.1111/j.1360-0443.2012.03811.x

  5. Meta-analysis of naltrexone and acamprosate for treating alcohol use disorders: when are these medications most helpful?

    Addiction

    Volume 108, Issue 2, February 2013, Pages: 275–293, Natalya C. Maisel, Janet C. Blodgett, Paula L. Wilbourne, Keith Humphreys and John W. Finney

    Version of Record online : 17 OCT 2012, DOI: 10.1111/j.1360-0443.2012.04054.x

  6. You have free access to this content
    Improving clinical outcomes for naltrexone as a management of problem alcohol use

    British Journal of Clinical Pharmacology

    Volume 76, Issue 5, November 2013, Pages: 632–641, Gary K. Hulse

    Version of Record online : 21 OCT 2013, DOI: 10.1111/j.1365-2125.2012.04452.x

  7. Opioid antagonists for alcohol dependence

    Intervention Review

    The Cochrane Library

    Susanne Rösner, Andrea Hackl-Herrwerth, Stefan Leucht, Simona Vecchi, Manit Srisurapanont and Michael Soyka

    Published Online : 8 DEC 2010, DOI: 10.1002/14651858.CD001867.pub3

  8. You have free access to this content
    Low-dose naltrexone for the treatment of fibromyalgia: Findings of a small, randomized, double-blind, placebo-controlled, counterbalanced, crossover trial assessing daily pain levels

    Arthritis & Rheumatism

    Volume 65, Issue 2, February 2013, Pages: 529–538, Jarred Younger, Noorulain Noor, Rebecca McCue and Sean Mackey

    Version of Record online : 28 JAN 2013, DOI: 10.1002/art.37734

  9. Naltrexone and Dysphoria: Fact or Myth?

    The American Journal on Addictions

    Volume 11, Issue 2, Spring 2002, Pages: 151–160, Karen Miotto, Michael McCann, Janice Basch, Richard Rawson and Walter Ling

    Version of Record online : 18 FEB 2010, DOI: 10.1080/10550490290087929

  10. Naltrexone, opiate addiction, and endorphins

    Medicinal Research Reviews

    Volume 2, Issue 3, July/September 1982, Pages: 211–246, Mark S. Gold, Charles A. Dackis, A. L. C. Pottash, Harvey H. Sternbach, William J. Annitto, David Martin and Marcy Pasternak Dackis

    Version of Record online : 18 SEP 2006, DOI: 10.1002/med.2610020302

  11. A randomized trial of naltrexone for smoking cessation

    Addiction

    Volume 94, Issue 8, August 1999, Pages: 1227–1237, Gilbert Y. Wong, Troy D. Wolter, Gary A. Croghan, Ivana T. Croghan, Kenneth P. Offord and Richard D. Hurt

    Version of Record online : 3 MAY 2002, DOI: 10.1046/j.1360-0443.1999.948122713.x

  12. Naltrexone maintenance for heroin dependence: uptake, attrition and retention

    Drug and Alcohol Review

    Volume 23, Issue 3, September 2004, Pages: 299–309, Dr THAMIZAN K. TUCKER, ALISON J. RITTER, CLAIRE MAHER and HENRY JACKSON

    Version of Record online : 29 MAY 2009, DOI: 10.1080/09595230412331289464

  13. Oral naltrexone maintenance treatment for opioid dependence

    Intervention Review

    The Cochrane Library

    Silvia Minozzi, Laura Amato, Simona Vecchi, Marina Davoli, Ursula Kirchmayer and Annette Verster

    Published Online : 13 APR 2011, DOI: 10.1002/14651858.CD001333.pub4

  14. Effects of Naltrexone Treatment for Alcohol-Related Disorders on Healthcare Costs in an Insured Population

    Alcoholism: Clinical and Experimental Research

    Volume 34, Issue 6, June 2010, Pages: 1090–1097, Henry R. Kranzler, Leslie B. Montejano, Judith J. Stephenson, Shaohung Wang and David R. Gastfriend

    Version of Record online : 5 APR 2010, DOI: 10.1111/j.1530-0277.2010.01185.x

  15. You have free access to this content
    Injectable and implantable sustained release naltrexone in the treatment of opioid addiction

    British Journal of Clinical Pharmacology

    Volume 77, Issue 2, February 2014, Pages: 264–271, Nikolaj Kunøe, Philipp Lobmaier, Hanh Ngo and Gary Hulse

    Version of Record online : 22 JAN 2014, DOI: 10.1111/bcp.12011

  16. You have free access to this content
    Kinetics and inhibition of the formation of 6β-naltrexol from naltrexone in human liver cytosol

    British Journal of Clinical Pharmacology

    Volume 50, Issue 5, November 2000, Pages: 465–471, Susan J. Porter, Andrew A. Somogyi and Jason M. White

    Version of Record online : 24 DEC 2001, DOI: 10.1046/j.1365-2125.2000.00281.x

  17. In vivo and in vitro potency studies of 6ß-naltrexol, the major human metabolite of naltrexone

    Addiction Biology

    Volume 7, Issue 2, April 2002, Pages: 219–225, SUSAN J. PORTER, ANDREW A. SOMOGYI and JASON M. WHITE

    Version of Record online : 9 JUN 2006, DOI: 10.1080/135562102200120442

  18. Single- and Multiple-Dose Pharmacokinetics of Long-acting Injectable Naltrexone

    Alcoholism: Clinical and Experimental Research

    Volume 30, Issue 3, March 2006, Pages: 480–490, Joi L. Dunbar, 1 Ryan Z. Turncliff, 1 Qunming Dong, 1 Bernard L. Silverman, 1 Elliot W. Ehrich and 1 Kenneth C. Lasseter 2

    Version of Record online : 13 FEB 2006, DOI: 10.1111/j.1530-0277.2006.00052.x

  19. Effects of the opioid receptor antagonist naltrexone on smoking and related behaviors in smokers preparing to quit: a randomized controlled trial

    Addiction

    Volume 108, Issue 10, October 2013, Pages: 1836–1844, Andrea King, Dingcai Cao, Lingjiao Zhang and Sandra Yu Rueger

    Version of Record online : 12 JUL 2013, DOI: 10.1111/add.12261

  20. Achieving long-term continuous blood naltrexone and 6-ß-naltrexol coverage following sequential naltrexone implants

    Addiction Biology

    Volume 9, Issue 1, March 2004, Pages: 67–72, GK Hulse, DE Arnold-Reed, G O'Neil, C-T Chan and RC Hansson

    Version of Record online : 9 JUN 2006, DOI: 10.1080/13556210410001674112